One of the more intriguing anti-terror drugs is a new anti-radiation injection called HE2100 that is being developed by San Diego-based Hollis-Eden Pharmaceuticals (nasdaq: HEPH - news - people ) in collaboration with the armed forces.
FORBES: Biotechs See Dollar Signs In War